# Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

> **NCT06663722** · PHASE2 · RECRUITING · sponsor: **University of Miami** · enrollment: 49 (estimated)

## Conditions studied

- Chronic Graft Versus Host Disease
- cGVHD

## Interventions

- **BIOLOGICAL:** Axatilimab
- **PROCEDURE:** Extracorporeal Photopheresis

## Key facts

- **NCT ID:** NCT06663722
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-05
- **Primary completion:** 2030-05-05
- **Final completion:** 2030-05-05
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06663722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06663722, "Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06663722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*